Conference
Efficacy and safety of the novel oral factor Xa inhibitor apixaban in atrial fibrillation (AF) patients with chronic kidney disease (CKD): the AVERROES trial
Authors
Hart RG; Eikelboom J; Yusuf S; Gao P; Paolasso E; De Caterina R; Husted S; Connolly SJ
Volume
32
Pagination
pp. 6-6
Publisher
OXFORD UNIV PRESS
Publication Date
August 1, 2011
Conference proceedings
EUROPEAN HEART JOURNAL
ISSN
0195-668X